MEI Pharma, Inc.·4

May 27, 1:35 PM ET

GOLD DANIEL P PHD 4

4 · MEI Pharma, Inc. · Filed May 27, 2021

Insider Transaction Report

Form 4
Period: 2021-05-25
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
  • Exercise/Conversion

    Common Stock

    2021-05-25$2.52/sh+5,000$12,600458,632 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-05-255,000675,000 total
    Exercise: $2.52Exp: 2029-07-01Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.
  • [F2]306,667 of the options are fully vested and currently exercisable. The remaining 368,333 options will vest in equal monthly installments through July 1, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION